Veru Inc (NASDAQ:VERU) issued its quarterly earnings results on Tuesday. The company reported ($0.03) EPS for the quarter, beating the Zacks’ consensus estimate of ($0.08) by $0.05, reports. Veru had a negative net margin of 73.86% and a negative return on equity of 20.72%.

Shares of Veru (NASDAQ:VERU) traded down 9.33% during mid-day trading on Tuesday, reaching $1.36. 56,532 shares of the company’s stock were exchanged. Veru has a one year low of $1.31 and a one year high of $1.45.

COPYRIGHT VIOLATION NOTICE: This news story was posted by Daily Political and is the property of of Daily Political. If you are viewing this news story on another domain, it was copied illegally and republished in violation of U.S. and international copyright and trademark laws. The correct version of this news story can be read at

Veru Company Profile

Veru Inc, formerly The Female Health Company, is a therapeutics company focused on developing and commercializing pharmaceuticals and devices in men’s and women’s health and oncology. The Company is engaged in the development, manufacture and marketing of consumer healthcare products. The Company has three divisions: Pharmaceutical and Devices, Consumer Health Products and Public Sector.

Receive News & Ratings for Veru Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veru Inc and related companies with's FREE daily email newsletter.